Pharmacokinetics and bioavailability of hydromorphone: effect of various routes of administration
- PMID: 2470073
- DOI: 10.1023/a:1015959912021
Pharmacokinetics and bioavailability of hydromorphone: effect of various routes of administration
Abstract
The pharmacokinetics and bioavailability of hydromorphone following various routes of administration, i.e., intravenous, oral, intranasal, and transdermal, were investigated in rabbits. Hydromorphone plasma concentrations were determined by reverse-phase high-performance liquid chromatography (HPLC). Comparison of area under the concentration versus time curve (AUC) between intravenous and oral administrations showed a low bioavailability of hydromorphone after oral administration. The nasal absorption of hydromorphone was studied by the in situ nasal recirculation technique, and the results showed that hydromorphone is well absorbed from the nasal mucosa. The transdermal permeation of hydromorphone was also evaluated for 24 hr and a steady-state plasma concentration (0.135 micrograms/ml) was achieved during the 6- to 24-hr periods following the application of a transdermal patch on the inner pinna of the rabbit's ear.
Similar articles
-
Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers.Anesth Analg. 2003 Jul;97(1):117-23, table of contents. doi: 10.1213/01.ane.0000066311.40978.4f. Anesth Analg. 2003. PMID: 12818953 Clinical Trial.
-
Pharmacokinetics of hydromorphone hydrochloride after intravenous and intramuscular administration of a single dose to American kestrels (Falco sparverius).Am J Vet Res. 2014 Jun;75(6):527-31. doi: 10.2460/ajvr.75.6.527. Am J Vet Res. 2014. PMID: 24866507 Clinical Trial.
-
Absolute bioavailability of hydromorphone after peroral and rectal administration in humans: saliva/plasma ratio and clinical effects.J Clin Pharmacol. 1987 Sep;27(9):647-53. doi: 10.1002/j.1552-4604.1987.tb03082.x. J Clin Pharmacol. 1987. PMID: 2445789
-
Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats.Biopharm Drug Dispos. 2002 Sep;23(6):239-44. doi: 10.1002/bdd.314. Biopharm Drug Dispos. 2002. PMID: 12214324
-
Pharmacokinetics of hydromorphone after intravenous, peroral and rectal administration to human subjects.Biopharm Drug Dispos. 1988 Mar-Apr;9(2):187-99. doi: 10.1002/bod.2510090207. Biopharm Drug Dispos. 1988. PMID: 2453226 Clinical Trial.
Cited by
-
Bioavailability and pharmacokinetics of intranasal hydromorphone in patients experiencing vasomotor rhinitis.Clin Drug Investig. 2004;24(11):633-9. doi: 10.2165/00044011-200424110-00002. Clin Drug Investig. 2004. PMID: 17523726
-
Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin.Pharm Res. 1989 Oct;6(10):825-32. doi: 10.1023/a:1015944018555. Pharm Res. 1989. PMID: 2575255
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources